Inari Medical Inc
NASDAQ:NARI
Balance Sheet
Balance Sheet Decomposition
Inari Medical Inc
Inari Medical Inc
Balance Sheet
Inari Medical Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
22
|
24
|
114
|
93
|
60
|
39
|
|
| Cash Equivalents |
22
|
24
|
114
|
93
|
60
|
39
|
|
| Short-Term Investments |
0
|
0
|
50
|
83
|
266
|
77
|
|
| Total Receivables |
2
|
11
|
28
|
42
|
59
|
70
|
|
| Accounts Receivables |
2
|
11
|
28
|
42
|
59
|
70
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
4
|
11
|
21
|
33
|
43
|
|
| Other Current Assets |
1
|
1
|
3
|
6
|
5
|
7
|
|
| Total Current Assets |
26
|
39
|
206
|
245
|
423
|
236
|
|
| PP&E Net |
1
|
3
|
8
|
61
|
72
|
69
|
|
| PP&E Gross |
1
|
3
|
8
|
61
|
72
|
69
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
5
|
9
|
14
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
151
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
214
|
|
| Long-Term Investments |
0
|
0
|
0
|
4
|
8
|
2
|
|
| Other Long-Term Assets |
0
|
2
|
1
|
1
|
1
|
3
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
214
|
|
| Total Assets |
27
N/A
|
45
+65%
|
214
+381%
|
312
+45%
|
504
+62%
|
674
+34%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
3
|
3
|
7
|
8
|
11
|
|
| Accrued Liabilities |
1
|
6
|
11
|
36
|
49
|
66
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
9
|
14
|
43
|
56
|
76
|
|
| Long-Term Debt |
10
|
20
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
36
|
|
| Other Liabilities |
0
|
1
|
0
|
30
|
31
|
97
|
|
| Total Liabilities |
12
N/A
|
30
+142%
|
14
-53%
|
72
+424%
|
87
+21%
|
209
+140%
|
|
| Equity | |||||||
| Common Stock |
54
|
54
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
40
|
41
|
27
|
18
|
47
|
48
|
|
| Additional Paid In Capital |
1
|
2
|
228
|
257
|
463
|
504
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
0
|
0
|
0
|
1
|
9
|
|
| Total Equity |
15
N/A
|
15
+2%
|
200
+1 235%
|
239
+19%
|
417
+74%
|
465
+11%
|
|
| Total Liabilities & Equity |
27
N/A
|
45
+65%
|
214
+381%
|
312
+45%
|
504
+62%
|
674
+34%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
46
|
46
|
49
|
50
|
54
|
58
|
|